Wordt geladen...
A novel antimetabolite: TAS-102 for metastatic colorectal cancer
TAS-102 is a new oral anti-tumor drug, composed of a thymidine-based nucleoside analog (trifluridine: FTD) and a thymidine phosphorylase inhibitor (tipiracil hydrochloride: TPI). TAS-102 has been shown to significantly improve overall survival and progression-free survival in patients with refractor...
Bewaard in:
| Gepubliceerd in: | Expert Rev Clin Pharmacol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485169/ https://ncbi.nlm.nih.gov/pubmed/26677869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17512433.2016.1133285 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|